Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR ...

FDA Recall #D-0205-2024 — Class II — December 11, 2023

Recall #D-0205-2024 Date: December 11, 2023 Classification: Class II Status: Ongoing

Product Description

Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, Packaged by: Legacy Pharmaceutical Packaging LLC., Earth City, MO 63045, NDC# 68645-523-54

Reason for Recall

CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.

Recalling Firm

Legacy Pharmaceutical Packaging LLC — Earth City, MO

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

161,664 bottles

Distribution

CA and AR

Code Information

Lot #: 222033, exp. date 08/31/2024

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated